DE69906729D1 - Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen - Google Patents

Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen

Info

Publication number
DE69906729D1
DE69906729D1 DE69906729T DE69906729T DE69906729D1 DE 69906729 D1 DE69906729 D1 DE 69906729D1 DE 69906729 T DE69906729 T DE 69906729T DE 69906729 T DE69906729 T DE 69906729T DE 69906729 D1 DE69906729 D1 DE 69906729D1
Authority
DE
Germany
Prior art keywords
composition
pseudomonas aeruginosa
aeruginosa infections
treating pseudomonas
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69906729T
Other languages
English (en)
Other versions
DE69906729T2 (de
Inventor
Randall T Irvin
Randy J Read
Bart Hazes
Wah Y Wong
Sastry Parimi
Linda M G Glasier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Alberta
Original Assignee
University of Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Alberta filed Critical University of Alberta
Publication of DE69906729D1 publication Critical patent/DE69906729D1/de
Application granted granted Critical
Publication of DE69906729T2 publication Critical patent/DE69906729T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69906729T 1998-06-12 1999-06-11 Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen Expired - Fee Related DE69906729T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8915598P 1998-06-12 1998-06-12
US89155P 1998-06-12
PCT/CA1999/000554 WO1999065511A2 (en) 1998-06-12 1999-06-11 Composition and method for treatment of pseudomonas infection

Publications (2)

Publication Number Publication Date
DE69906729D1 true DE69906729D1 (de) 2003-05-15
DE69906729T2 DE69906729T2 (de) 2004-02-05

Family

ID=22215992

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69906729T Expired - Fee Related DE69906729T2 (de) 1998-06-12 1999-06-11 Zusammensetzung und methode zur behandlung von pseudomonas aeruginosa infektionen

Country Status (6)

Country Link
US (2) US6342233B1 (de)
EP (1) EP1083922B1 (de)
AU (1) AU4253999A (de)
CA (1) CA2329689A1 (de)
DE (1) DE69906729T2 (de)
WO (1) WO1999065511A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5931315A (en) * 1994-08-02 1999-08-03 Lorentz; Hilel Modular storage and display device
EP1919494A4 (de) 2005-07-22 2011-11-09 Univ Colorado Regents Nichttoxischer biofolien-hemmer

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5343390A (en) * 1989-03-31 1990-11-05 Immunomed Corporation Preparation of unassembled pilus subunits and vaccines containing them
CA1340530C (en) 1989-04-28 1999-05-04 Kok Kheong Lee Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics
US5494672A (en) * 1989-04-28 1996-02-27 S.P.I. Synthetic Peptides Incorporated Pseudomonas peptide composition and method
US5223604A (en) * 1991-06-25 1993-06-29 S.P.I. Synthetic Peptides Incorporated Pseudomonas exoenzyme s peptide composition and method
AU3416693A (en) * 1991-12-18 1993-07-19 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University, The Antigenic preparations that stimulate production of antibodies which bind to the pili of type IV piliated bacteria
WO1995031480A1 (en) 1994-05-18 1995-11-23 S.P.I. Synthetic Peptides Incorporated Heterodimer polypeptide immunogen carrier composition and method
WO1997012988A1 (en) 1995-10-06 1997-04-10 Pence Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins
EP0983303B1 (de) 1997-05-21 2006-03-08 Biovation Limited Verfahren zur herstellung von nicht-immunogenen proteinen

Also Published As

Publication number Publication date
WO1999065511A2 (en) 1999-12-23
EP1083922A2 (de) 2001-03-21
US6767545B2 (en) 2004-07-27
CA2329689A1 (en) 1999-12-23
US6342233B1 (en) 2002-01-29
WO1999065511A3 (en) 2000-03-02
EP1083922B1 (de) 2003-04-09
AU4253999A (en) 2000-01-05
US20020098196A1 (en) 2002-07-25
DE69906729T2 (de) 2004-02-05

Similar Documents

Publication Publication Date Title
DE69810584T2 (de) Verfahren und Methode zur Behandlung von Abfällen
DE60035378D1 (de) Gerät zur Behandlung von Bandscheiben
DE69711034D1 (de) Wässrige fluorpolymerlösungen zur behandlung von harten oberflächen
DE60011570D1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
ATE254458T1 (de) Antibiotische zusammensetzungen zur behandlung des auges
DE69603089T2 (de) Zusammensetzung zur behandlung von mauerwerk
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE60034871D1 (de) Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust
DE60114439D1 (de) Verfahren zur antimikrobiellen behandlung von fasermaterialien
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE69905616T2 (de) Verfahren und zusammensetzung zur behandlung und vorbeugung von mycobacterium infektionen
ATE493145T1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE69916629D1 (de) Taurolidin und/oder taurultam zur behandlung von infektiösen ulcera oder gastritis
DE69709390T2 (de) Anordnungen und verfahren zur desinfektion von kontaktlinsen
DE69835419D1 (de) Verfahren zur Behandlung von organischem Abwasser
ATE415163T1 (de) Verfahren und zusammensetzungen zur behandlung von augenerkrankungen
DE60027429D1 (de) Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien
DE60021948D1 (de) Verfahren zur Behandlung von Kontaktlinsen
DE69900339T2 (de) Mittel und Verfahren zur Behandlung von Kunstfasern
DE60001255T2 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
ATE347888T1 (de) Verwendung von aivlosin zur behandlung und prevention der lawsonia-infektionen in schweinen.
DE69904849D1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee